Daniel VIAL - PowerPoint PPT Presentation

Loading...

PPT – Daniel VIAL PowerPoint presentation | free to download - id: fa394-ZDc1Z



Loading


The Adobe Flash plugin is needed to view this content

Get the plugin now

View by Category
About This Presentation
Title:

Daniel VIAL

Description:

Il Futuro Dell'Industria Farmaceutica - 21 settembre 2007. 3 ... CHINE. 10 countries: 80% of drugs' consumption (in value) Top 10 market rankings to 2010 ... – PowerPoint PPT presentation

Number of Views:42
Avg rating:3.0/5.0
Slides: 16
Provided by: tda17
Learn more at: http://www.assolombarda.it
Category:
Tags: vial | chine | daniel

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: Daniel VIAL


1
Global Pharmaceutical Perspective
  • Daniel VIAL
  • Vicepresidente
  • IMS Europe
  • Milano - 21 settembre 2007

2
Global pharmaceutical sales643 billions US in 06
constant US growth
Billions US
In billions USD 1999 2000 2001 2002 2003 2004 2005 2006
Total World market 334 362 387 427 498 559 601 643
Constant US growth 14.5 11.7 11.8 10.6 10.4 8.0 6.8 7.0
Source IMS Health, IMS Market Prognosis
International, Feb 2007

3
2006 market dynamic is different accordingto
the region
Source IMS Health - Global Pharma Forecasts,
March 2007
4
2006 within the region, market dynamic is
different according to the country
Constant dollar
Source IMS Health MIDAS Retail market
5
Contribution to growthEmerging market contribute
to 27 of the total growth
2001 25.5 Billions US
2006 42.4 Billions US
CONTRIBUTION
Source IMS Health, IMS Market Prognosis
International, Feb 2007
6
Number of Global BlockbustersFor the first time,
specialist driven drugs represent half of the
blockbusters
49
Number of Blockbusters
25
51
75
Source IMS Health, MIDAS, MAT Dec 2006, Market
Insights Team research
7
Protection status in 5 key markets
14
7
11
11
4
7
17
12
6
12
-2
-28
10
-22
-9
-22
-20
-15
14
15
9
11
13
16
Source IMS Health, MIDAS, New Market
Segmentation, RX only, MAT Dec 2006
8
Italian retail market reimbursable drugs Since
the 2nd semester 06, a regular decrease of the
growth for the units and a negative growth in
value
10.3
5.9
4.7
2.7
- 3.4
-9
in public price
9
Italian retail market reimbursable drugsIn
units, the reimbursable market is becoming flat
Units
10
Italian retail market reimbursable drugsIn
value, the reimbursable market is declining
In
-9
in public price
11
Italian pharma RD Growth of pharma RD
investment is higher than the restof the
industry during the last 6 years
RD investment - in million
24.7
18.9
12
Italian pharma RD of workers in the RD
In of total employees
Rate of workers in pharma RD is much more higher
than in the industry
13
RD drugs in active development
Belgium 401 - Poland 155
Source IMS Health RD Focus
14
Top 10 market rankings to 2010 China just behind
the old Europe
2002
2010
1 USA
2 JAPON
3 ALLEMAGNE
4 FRANCE
5 ITALIE
6 UK
7 ESPAGNE
8 CANADA
9 BRESIL
10 CHINE
1 USA
2 JAPON
3 FRANCE
4 ALLEMAGNE
5 UK
6 ITALIE
7 CHINE
8 CANADA
9 ESPAGNE
10 BRESIL
  • Italy will be the 6th country in term of drugs
    consumption (in value)
  • China will be the 7st country in term of drugs
    consumption (in value)
  • Turkey, South Korea and India will be closed to
    Top 10

Source IMS Health -IMS Market Prognosis
2002-2010
15
Thank you very much for your attention .
  • Daniel VIAL
  • Vicepresidente
  • IMS Europe
  • dvial_at_fr.imshealth.com
About PowerShow.com